Oticon

Last updated

Oticon
Founded1904
FounderHans Demant
Headquarters
Smørum, Egedal
,
Denmark
Products Hearing aids
Number of employees
3000+
Parent Demant A/S

Oticon is a hearing aid manufacturer based in Copenhagen, Denmark. The company is a subsidiary of Demant A/S. It was founded in 1904 by Hans Demant, whose wife was hearing impaired. The company claims to be the world's second-largest manufacturer of hearing aids, and uses a management style known as "spaghetti organization" [1] [2] introduced by Lars Kolind [3] [4] [5] under his leadership between 1988 and 1998. [6] [7] [8]

Contents

Oticon has branches in several countries, including a production plant in Poland, with more than 3,000 employees worldwide. [9]

Oticon hearing aid Intra aural hearing aid Wellcome L0065955.jpg
Oticon hearing aid

Oticon Medical

Oticon Medical is a sister company of Oticon, both being subsidiaries of the Demant Group. [10] Whereas Oticon specialises in hearing aids, Oticon Medical specialises in hearing implants and released its first products in 2009. [11] The company's Ponto bone conduction implant is now in its fifth generation. [12]

In 2013, Oticon Medical acquired Neurelec, a French producer of cochlear implants. [13]

In April 2022, Demant announced it had agreed to sell Oticon Medical to Australian company Cochlear Limited for DKK850 million and would exit the hearing implant business. [14]

Related Research Articles

<span class="mw-page-title-main">Cochlear implant</span> Prosthesis

A cochlear implant (CI) is a surgically implanted neuroprosthesis that provides a person who has moderate-to-profound sensorineural hearing loss with sound perception. With the help of therapy, cochlear implants may allow for improved speech understanding in both quiet and noisy environments. A CI bypasses acoustic hearing by direct electrical stimulation of the auditory nerve. Through everyday listening and auditory training, cochlear implants allow both children and adults to learn to interpret those signals as speech and sound.

Sennheiser electronic GmbH & Co. KG is a German audio equipment manufacturer headquartered in Wedemark. Sennheiser specializes in equipment for both the consumer and professional audio markets, including microphones, headphones, and loudspeakers.

<span class="mw-page-title-main">Hearing aid</span> Electroacoustic device

A hearing aid is a device designed to improve hearing by making sound audible to a person with hearing loss. Hearing aids are classified as medical devices in most countries, and regulated by the respective regulations. Small audio amplifiers such as personal sound amplification products (PSAPs) or other plain sound reinforcing systems cannot be sold as "hearing aids".

Bone conduction is the conduction of sound to the inner ear primarily through the bones of the skull, allowing the hearer to perceive audio content even if the ear canal is blocked. Bone conduction transmission occurs constantly as sound waves vibrate bone, specifically the bones in the skull, although it is hard for the average individual to distinguish sound being conveyed through the bone as opposed to the sound being conveyed through the air via the ear canal. Intentional transmission of sound through bone can be used with individuals with normal hearing — as with bone-conduction headphones — or as a treatment option for certain types of hearing impairment. Bones are generally more effective at transmitting lower-frequency sounds compared to higher-frequency sounds.

<span class="mw-page-title-main">Audiology</span> Branch of science that studies hearing, balance, and related disorders

Audiology is a branch of science that studies hearing, balance, and related disorders. Audiologists treat those with hearing loss and proactively prevent related damage. By employing various testing strategies, audiologists aim to determine whether someone has normal sensitivity to sounds. If hearing loss is identified, audiologists determine which portions of hearing are affected, to what degree, and where the lesion causing the hearing loss is found. If an audiologist determines that a hearing loss or vestibular abnormality is present, they will provide recommendations for interventions or rehabilitation.

Demant A/S is a Danish multinational company involved with hearing care, hearing aids, audiometric equipment and personal communication devices.

<span class="mw-page-title-main">Sonova</span> Swiss hearing care company group

Sonova Holding AG is an internationally active Swiss group of companies headquartered in Stäfa that specializes in hearing care. The Sonova group operates through its core business brands Phonak, Unitron, Hansaton, Advanced Bionics, AudioNova and Sennheiser. It is one of the largest providers in the sector worldwide. The group and its brands hold 24% of the global hearing aid market in sales. As of 11 September 2022, Sonova was a component of the Swiss Market Index.

<span class="mw-page-title-main">Bone-anchored hearing aid</span>

A bone-anchored hearing aid (BAHA) is a type of hearing aid based on bone conduction. It is primarily suited for people who have conductive hearing losses, unilateral hearing loss, single-sided deafness and people with mixed hearing losses who cannot otherwise wear 'in the ear' or 'behind the ear' hearing aids. They are more expensive than conventional hearing aids, and their placement involves invasive surgery which carries a risk of complications, although when complications do occur, they are usually minor.

<span class="mw-page-title-main">Cochlear Limited</span> Australian public company

Cochlear is a medical device company that designs, manufactures, and supplies the Nucleus cochlear implant, the Hybrid electro-acoustic implant and the Baha bone conduction implant.

<span class="mw-page-title-main">Royal National Throat, Nose and Ear Hospital</span> Hospital in London, England

The Royal National Throat, Nose and Ear Hospital was a health facility on Gray's Inn Road in London. It closed in October 2019 when services transferred to the new Royal National ENT and Eastman Dental Hospitals on Huntley Street, London, WC1E 6DG. The Huntley Street hospital continues to provide specialist ENT, sleeps and allergy services and is part of University College London Hospitals NHS Foundation Trust.

Auditory-verbal therapy is a method for teaching deaf children to listen and speak using their hearing technology. Auditory-verbal therapy emphasizes listening and seeks to promote the development of the auditory brain to facilitate learning to communicate through talking. It is based on the child's use of optimally fitted hearing technology.

Geoffrey R. Ball (born 1964) is an American physiologist specializing in Biomechanics and the inventor of the VIBRANT SOUNDBRIDGE active middle ear implant – a medical device designed to treat his own hearing loss.

<span class="mw-page-title-main">Lars Kolind</span> Danish businessman

Lars Kolind is a Danish businessman. Kolind holds an M.Sc. in Mathematics from Aarhus University from 1972 and a B.Comm. from the Copenhagen Business School from 1977. He is adjunct professor of leadership and strategy at Aarhus University Business School since 2000. He serves as Detao Master of Leadership and Strategy since 2012.

<span class="mw-page-title-main">Ingeborg Hochmair</span> Austrian electrical engineer

Ingeborg J. Hochmair-Desoyer is an Austrian electrical engineer and the CEO and CTO of hearing implant company MED-EL. Dr Hochmair and her husband Prof. Erwin Hochmair co-created the first micro-electronic multi-channel cochlear implant in the world. She received the Lasker-DeBakey Clinical Medical Research Award for her contributions towards the development of the modern cochlear implant. She also received the 2015 Russ Prize for bioengineering.

Deafness has varying definitions in cultural and medical contexts. In medical contexts, the meaning of deafness is hearing loss that precludes a person from understanding spoken language, an audiological condition. In this context it is written with a lower case d. It later came to be used in a cultural context to refer to those who primarily communicate through sign language regardless of hearing ability, often capitalized as Deaf and referred to as "big D Deaf" in speech and sign. The two definitions overlap but are not identical, as hearing loss includes cases that are not severe enough to impact spoken language comprehension, while cultural Deafness includes hearing people who use sign language, such as children of deaf adults.

Cochlear Bone Anchored Solutions is a company based in Gothenburg, Sweden that manufactures and distributes bone conduction hearing solutions under the trademark Baha. The company was founded in 1999 under the name Entific Medical Systems. When Cochlear bought the company in 2005, the name was changed to Cochlear Bone Anchored Solutions. The acronym "BAHA" was trademarked into Baha, as it is not considered a hearing aid by insurance companies.

<span class="mw-page-title-main">MED-EL</span> Multinational medical device company

MED-EL is a global medical technology company specializing in hearing implants and devices. They develop and manufacture products including cochlear implants, middle ear implants and bone conduction systems. 

<span class="mw-page-title-main">Bionics Institute</span>

The Bionics Institute is an Australian medical research institute focusing on medical device development. It is located in Melbourne, Australia.

<span class="mw-page-title-main">Mohan Kameswaran</span> Indian otorhinolaryngologist and medical academic

Mohan Kameswaran is an Indian otorhinolaryngologist, medical academic and the founder of MERF Institute of Speech and Hearing, a Chennai-based institution providing advanced training in audiology and speech-language pathology. He is one of the pioneers of cochlear implant surgery in India and a visiting professor at Rajah Muthiah Medical College of the Annamalai University and Sri Ramachandra Medical College and Research Institute, Chennai. He has many firsts to his credit such as the performance of the first auditory brain stem implantation surgery in South and South East Asia, the first pediatric brain stem implantation surgery in Asia, the first totally implantable hearing device surgery in Asia Pacific region, and the first to introduce KTP/532 laser-assisted ENT surgery in India. The Government of India awarded him the fourth highest civilian honour of the Padma Shri, in 2006, for his contributions to Indian medicine.

Treatment depends on the specific cause if known as well as the extent, type, and configuration of the hearing loss. Most hearing loss results from age and noise, is progressive, and irreversible. There are currently no approved or recommended treatments to restore hearing; it is commonly managed through using hearing aids. A few specific types of hearing loss are amenable to surgical treatment. In other cases, treatment involves addressing underlying pathologies, but any hearing loss incurred may be permanent.

References

  1. "Oticon A/S: Spaghetti Organization and Beyond". IBS Center for Management Research. Retrieved 12 September 2012.
  2. "Case Study: Revolution at Oticon A/S: The Spaghetti Organization (Condensed)". Harvard Business Review. Retrieved 10 September 2012.
  3. Peters, Tom (January 1994). Liberation Management . United States: Ballantine Books. p.  880. ISBN   0-449-90888-7.
  4. Ewing, Jack (6 August 2007). "Denmark's Masters of E-Mail Marketing". Bloomberg Businessweek. Archived from the original on 9 July 2012. Retrieved 12 September 2012.
  5. Poulsen, Per Thygesen (1993). Tænk det utænkelige: Revolutionen i Oticon. Denmark: Schultz Erhvervsbøger. p. 174. ISBN   87-569-7920-7.
  6. Tænk det utænkelige: Revolutionen i Oticon. 1993. ISBN   9788756979207 . Retrieved 12 September 2012.
  7. "Think the Unthinkable (in Danish: Tænk det utænkelige!)". Kolind Kuren. Retrieved 12 September 2012.
  8. Morsing, Mette; Eiberg, Kristian (1998). Managing the Unmanageable for a Decade. Denmark: Oticon A/S. p. 244.
  9. "Oticon Hearing Aids". Apex Hearing. Retrieved 6 May 2014.
  10. "Oticon Medical – A company founded on care". earcommunity.org. Retrieved 24 March 2022.
  11. "Our history". www.demant.com. Retrieved 24 March 2022.
  12. "Oticon Medical bone-anchored hearing devices". Healthy Hearing. Retrieved 24 March 2022.
  13. Apr 2; Ear, 2013 | Behind the; Implants, Cochlear; News | 0 |, Industry (2 April 2013). "William Demant Acquires Neurelec, a French Manufacturer of Cochlear Implants". The Hearing Review. Retrieved 24 March 2022.{{cite web}}: CS1 maint: numeric names: authors list (link)
  14. Ogg, Matt (27 April 2022). "Cochlear to acquire loss-making Oticon Medical for $170 million". Business News Australia. Retrieved 6 May 2022.